Cite
HARVARD Citation
Garralda, E. et al. (n.d.). Dose escalation study of OMO-103, a first in class Pan-MYC-Inhibitor in patients (pts) with advanced solid tumors. European journal of cancer. pp. S5-S6. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Garralda, E. et al. (n.d.). Dose escalation study of OMO-103, a first in class Pan-MYC-Inhibitor in patients (pts) with advanced solid tumors. European journal of cancer. pp. S5-S6. [Online].